Proteins of hepatitis B surface antigen [PDF]
Journal of Virology, 1977 Purified 22-nm forms of hepatitis B surface antigen (Hbsag) representing the three major antigenic subtypes (adw, ayw, and adr) were analyzed for their constituent polypeptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. No consistent difference in either the number or relative distributions of the polypeptides was observed for the ...
J W Shih, John L. Gerin
openalex +3 more sources
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B [PDF]
Hepatology International, 2012 Abstract Background We investigated the differences in HBsAg kinetics at different levels of viremia in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). Methods We compared HBsAg levels among HBeAg-negative CHB patients with persistently undetectable HBV ...
Wai‐Kay Seto +7 more
openalex +4 more sources
Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens [PDF]
Infection and Immunity, 1984 F. Audibert +6 more
openalex +2 more sources
Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients [PDF]
Vojnosanitetski Pregled, 2023 Background/Aim. Quantitative hepatitis B virus (HBV) surface antigen (qHBsAg) has become increasingly wide-spread in the last few years in both diagnostic and therapeutic protocols for HBV infection.
Pete Maria +5 more
doaj +1 more source
Immunogenicity of transgenic plant-derived hepatitis B surface antigen.
Proceedings of the National Academy of Sciences of the United States of America, 1995 Yasmin Thanavala +4 more
openalex +3 more sources
Prevalence of hepatitis B in dental patients
Journal of Indian Academy of Oral Medicine and Radiology, 2023 Background: Hepatitis B virus (HBV) infection is one of the leading causes of death worldwide. The most important marker for HBV infection is HBsAg. In case of diagnosis of infectious disease, discordant results may have serious consequences among the ...
Ashmita Kaur R. Chawla +2 more
doaj +1 more source
Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence [PDF]
Journal of Pathology and Translational Medicine, 2016 Background: Hepatitis B virus (HBV) plays well-known roles in tumorigenesis of hepatocellular carcinoma (HCC) in infected patients. However, HBV-associated protein status in tumor tissues and the relevance to tumor behavior has not been reported.
Jing Jin +6 more
doaj +1 more source
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm [PDF]
Clinical and Molecular Hepatology, 2023 Nucleos(t)ide analogues (NA) are widely used to treat hepatitis B virus (HBV) infection, but they cannot eradicate the virus and treatment duration can be lifelong if the endpoint is set at seroclearance of the hepatitis B surface antigen (HBsAg).
Yao-Chun Hsu +2 more
doaj +1 more source
Hepatology, 2020 ARC‐520, the first an RNA interference (RNAi) therapeutic, was designed to reduce all RNA transcripts derived from covalently closed circular DNA, leading to a reduction in viral antigens and hepatitis B virus (HBV) DNA.
M. Yuen +17 more
semanticscholar +1 more source
Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance [PDF]
Clinical and Molecular Hepatology, 2021 Background/Aims The role of hepatitis B virus (HBV) integration into the host genome in hepatocarcinogenesis following hepatitis B surface antigen (HBsAg) seroclearance remains unknown.
Jeong Won Jang +9 more
doaj +1 more source